408 — Yips Chemical Holdings Balance Sheet
0.000.00%
- HK$1.06bn
- HK$1.80bn
- HK$3.16bn
- 53
- 92
- 45
- 73
Annual balance sheet for Yips Chemical Holdings, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | C2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 565 | 783 | 1,088 | 854 | 594 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 3,967 | 5,306 | 3,464 | 1,404 | 1,404 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 5,702 | 7,395 | 4,973 | 2,654 | 2,359 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 2,067 | 2,501 | 1,181 | 1,070 | 979 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 8,439 | 10,420 | 8,012 | 6,419 | 6,076 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 3,197 | 4,654 | 3,145 | 1,967 | 1,927 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 5,033 | 6,618 | 3,605 | 2,493 | 2,287 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 3,406 | 3,802 | 4,407 | 3,926 | 3,789 |
| Total Liabilities & Shareholders' Equity | 8,439 | 10,420 | 8,012 | 6,419 | 6,076 |
| Total Common Shares Outstanding |